Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 study of NexoBrid for enzymatic eschar removal in thermal burns
2014-001672-55Phase 3Completed
- Sponsor
- MediWound
- Start
- Jun 2014
- Modality
- Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in thermal injury comparing NexoBrid enzymatic debridement, Gel Vehicle and Standard of Care (3 arms). Primary endpoint: Complete eschar removal vs Gel Vehicle (per patient). Started Jun 2014; status: completed.
02
Drugs
bromelain
03
Conditions
thermal injury
Beyond the preview
Go deeper on 2014-001672-55.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-001672-55.